Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Older hepatitis C patients prove difficult to treat
Chronic hepatitis C virus (HCV) was seen in the Japanese population decades before the US, with the result that HCV patients in Japan are 10 to 15 years
Chronic hepatitis C virus (HCV) was seen in the Japanese population decades before the US, with the result that HCV patients in Japan are 10 to 15 years
This investigation is the first to indicate that the drug trastuzumab (marketed by Genentech as Herceptin) may work better when it is followed by injections of interleukin (IL)
The license is a result of an ongoing collaborative research effort between the two companies to create novel folate conjugates of Bristol-Myers Squibb’s proprietary epothilone compounds. The conjugates
RheoGene has developed technology to manage gene expression, a key component of gene-based therapies. RheoGene’s therapeutic system uses a patented small-molecule mediator that can turn genes ‘on’ or
Cethromycin will be evaluated using a 300mg once-daily dosing regimen over a seven-day course of therapy. The clinical cure rate at the ‘test-of-cure’ visit will be the primary
For many patients suffering from depressive illnesses the best pharmacological treatments are those that increase levels of serotonin, the brain chemical that regulates mood, sleep and memory. New
Developed in the 1960s at Wistar, the rubella vaccine has eradicated the disease in the US, according to the US Centers for Disease Control and Prevention. Due to
Under the terms of the agreement, Prism will pay Commonwealth Biotechnologies (CBI) a nominal signing fee, milestone payments against product approvals, and royalties from net product sales. Milestone
This development was enabled by the unexpected discovery that a tiny change in a rabies virus protein can turn a “safe” virus extremely deadly. Scientists at Jefferson Medical
The study showed that a three-month course of treatment with antibiotics could decrease the recurrence of cardiovascular events in patients without periodontitis, an infection of the gingiva or